Company BioSig Technologies Inc Other OTC
Equities
US09073N1028
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
BioSig
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -93.71% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -93.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 09-02-23 |
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Investor Relations Contact | - | 19-10-28 | |
Katie Freshwater
SAM | Sales & Marketing | - | 22-09-30 |
Zachary Koch
PRN | Corporate Officer/Principal | - | 21-12-31 |
Ewald Riechert
LAW | General Counsel | - | - |
Brenda Castrodad
HRO | Human Resources Officer | - | 21-02-15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,198,174 | 9,091,984 ( 81.19 %) | 0 | 81.19 % |
Stock B | 0 | 105 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+7.71% | 220B | |
+6.25% | 185B | |
+10.60% | 133B | |
+26.73% | 107B | |
-0.57% | 62.91B | |
+15.42% | 53.34B | |
-1.89% | 47.71B | |
-1.91% | 40.29B | |
+11.16% | 39.57B |